Eligible workers get certain Type 2 diabetes GLP-1 drugs free as part of a benefits expansion covering more than 250 prescriptions, even as starter plan premiums rise.
Recap by typeshit. Full story at Fox Business.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
A Penn study in JAMA Health Forum compared 9 covering states with 36 that don't. Obesity-labeled scripts rose 6.48 per 1,000, but total use grew less.
Cheap Medicine Shop and Online Generic Medicine got warning letters in September for selling Semanext and Semanat injections to US buyers without approval.
Loading…